A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28

from Talking Precision Medicine · host Genialis

In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member. Visit TPM E28 for highlights and links from this episode.

Episode metadata supplied by the publisher feed · Published Nov 30, 2022

Embed this episode

Attribution link and audio player

Ready to play

A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28

0:00 45:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Precision Medicine?

This episode is 45 minutes long.

When was this Talking Precision Medicine episode published?

This episode was published on November 30, 2022.

Can I download this Talking Precision Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!